
Morphisec
Automated Moving Target Defense that stops ransomware and zero-day attacks pre-execution
About Morphisec
Morphisec is an endpoint security vendor built around Automated Moving Target Defense (AMTD), a prevention-first technique it pioneered and patented from research at Ben-Gurion University that randomizes application memory at runtime so malicious code cannot execute. Its Anti-Ransomware Assurance Suite adds a preexecution prevention layer beneath existing endpoint detection and response tools, targeting ransomware, fileless, and zero-day attacks. Founded in 2014, Morphisec protects more than 7,000 organizations and over 9 million endpoints across healthcare, financial services, manufacturing, and technology. The company has raised roughly $62.6 million in venture funding, including from Orange Digital Ventures, and moved its global headquarters to New York while keeping an R&D center in Be'er Sheva, Israel.
Portfolio
Products by Morphisec
· 0 productsNo products listed for this vendor yet.
Is this your company?
Claim your profile to update information, showcase your products, and connect with teams looking for your solutions.
Info last updated on August 12, 2026